secwatch.observer — SEC 8-K summary
======================================

Issuer:     VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK:        0000875320
Form:       8-K
Filed at:   2025-05-19T23:59:59+00:00
Accession:  0000875320-25-000199
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Vertex Pharmaceuticals authorizes $4.0B share repurchase program
----------------------------------------------------------------

- Board authorized new $4.0B stock repurchase program (2025 Repurchase Program) with no expiration date.
- Combined with ~$775M remaining under 2023 program, total authorization rises to ~$4.775B.
- Repurchases may be made on open market or private transactions, including under Rule 10b5-1 plans.
- Company can discontinue program at any time; repurchases subject to market conditions and other opportunities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875320/000087532025000199/0000875320-25-000199-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875320/000087532025000199/vrtx-20250519.htm
  HTML page:      https://secwatch.observer/filing/0000875320-25-000199

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer